HNF-32934-12823
3 vaccinations
3 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 031 / NH
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Dose 1 — Moderna
-
2021-01-16
Registered in v-safe
- 2021-01-16
- 2021-01-23
- 2021-01-30
-
2021-02-06
Dose 2 — Moderna
-
2021-02-13
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-20
-
2021-02-27
Survey response — day 21, dose 2MedDRA: Fatigue, Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe fatigue and muscle painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-13
Survey response — day 35, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
- 2021-05-08
- 2021-08-07
-
2022-01-07
Dose 3 — Moderna
- 2022-01-10
- 2022-01-11
- 2022-01-12
- 2022-01-13
- 2022-01-14
- 2022-01-23
- 2022-01-30
- 2022-02-04
- 2022-02-13
- 2022-02-20
- 2022-04-08
- 2022-07-08
-
2023-01-07
Survey response — 12 months, dose 3MedDRA: Costochondritis, Muscle rupture, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-07
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Moderna | |
| 2 | 2021-02-06 | Moderna | |
| 3 | 2022-01-07 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 21, dose 2
Symptoms: Severe fatigue and muscle pain
Release 5 — day 35, dose 2
Symptoms: Migraine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Costochondritis | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Muscle rupture | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release